CoolSculpting® Exhibiting at Summer AAD 2013
July 31 2013 - 8:00AM
Business Wire
ZELTIQ® Aesthetics, Inc. (Nasdaq: ZLTQ), a medical
technology company focused on developing and commercializing
products utilizing its proprietary controlled-cooling technology
platform, today announced it is exhibiting at the summer meeting of
the American Academy of Dermatology (AAD) in New York, July
31-August 4, 2013. The company is showcasing CoolSculpting, its
non-surgical, clinically proven procedure designed to selectively
reduce fat in treated areas using a patented cooling
technology.
For the complete summer AAD program, visit www.aad.org. For
information about CoolSculpting, visit ZELTIQ at Booth #821.
WHAT:
CoolSculpting ZELTIQ Booth #821
WHEN:
Summer AAD Exhibit Hours Thursday, August 1, 2013, 10:00 a.m. –
6:00 p.m. Friday, August 2, 2013, 10:00 a.m. – 6:00 p.m.
WHERE:
American Academy of Dermatology (AAD) Summer Meeting Hilton New
York Hotel 1335 Avenue of the Americas New York, NY 10019
About ZELTIQ® Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ’s first commercial
product, the CoolSculpting System, is designed to selectively
reduce stubborn fat that may not respond to diet or exercise.
CoolSculpting is based on the scientific principle that fat cells
are more sensitive to cold than the overlying skin and surrounding
tissues. It utilizes patented technology of precisely controlled
cooling to reduce the temperature of fat cells in the treated area,
which is intended to cause fat cell elimination through a natural
biological process known as apoptosis. ZELTIQ developed
CoolSculpting to safely, noticeably and measurably reduce the fat
layer.
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024